Construction of A Clinical Prediction Model for Overall Survival and Cancer-Specific Survival in Malignant Phyllode Tumor of the Breast Based on the SEER Database

Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Objective Malignant Phyllodes Tumor of the Breast (MPTB) represents a distinct breast tumor subtype associated with a poor prognosis. The objective of this research was to create and verify a nomogram to predict both overall survival (OS) and breast cancer-specific survival (BCSS) for individuals with a diagnosis of MPTB. Methods From the Surveillance, Epidemiology, and End Results (SEER) database, clinicopathological data of MPTB patients diagnosed between 2000 and 2020 were collected. We performed logistic regression analyses to determine the independent factors that predict both OS and BCSS. Subsequently, a nomogram was developed integrating these significant predictors. Model performance was assessed using metrics such as the calibration curve, area under receiver operating characteristic curve (AUC), and decision curve analysis (DCA). Based on the nomogram scores, patients were categorized into low-risk and high-risk groups, and survival differences were then assessed through the log-rank test and Kaplan-Meier curves. Results The study encompassed 1692 MPTB patients, randomly allocated into a training cohort (N = 1188, 70%,) and a validation cohort (N = 504, 30%). Eight independent predictors for OS were identified through univariate and multivariate analyses: age, marital status, income, stage, tumor stage, nodal stage, surgery, and chemotherapy. Additionally, six independent predictors for BCSS were identified through the same analytical approach: age, stage, tumor stage, nodal stage, surgery, and chemotherapy. Nomograms were constructed based on these variables to forecast OS and BCSS rates for patients with MPTB. Evaluation of the model's discriminative ability using AUC demonstrated satisfactory predictive performance for OS and BCSS in both cohorts. Strong concordance between the probabilities observed and those predicted was indicated by the calibration curve. Furthermore, DCA underscored the clinical utility of the nomogram. Conclusions In this investigation, a nomogram was effectively constructed and internally confirmed to forecast OS and BCSS among individuals with MPTB. This predictive tool provides clinicians with essential prognostic information to guide their clinical decision-making processes.

Article activity feed